Navigation Links
GEN reports on novel noninvasive tests for early cancer detection
Date:5/3/2011

New Rochelle, NY, May 3, 2011Researchers at last month's AACR conference in Orlando demonstrated that they are intensifying their efforts to identify and validate various types of biomarkers that are detectable in readily accessible bodily fluids such as blood and urine, reports Genetic Engineering & Biotechnology News (GEN). The goal is to detect biosignatures that are more specific and sensitive than existing diagnostic modalities, according to the May 1 issue of GEN (http://www.genengnews.com/gen-articles/cancer-detection-improved-with-noninvasive-testing/3639/).

"The molecular diagnostic approach is geared toward finding tumors earlier in the course of disease," says John Sterling, Editor in Chief of GEN. "This could reduce the need for more invasive and costly biopsies and imaging studies and lead to earlier therapeutic intervention."

At the AACR meeting, Harvey Pass, M.D., New York University Langone Medical Center and Cancer Center, discussed his group's experience working in collaboration with SomaLogic to develop an aptamer-based diagnostic to detect malignant mesothelioma in asbestos-exposed individuals. Dr. Pass presented data derived from the application of biomarker subsets to a blinded test set, demonstrating 100% specificity and 80% sensitivity for their ability to distinguish asbestos-exposed controls from mesothelioma cases.

Another presentation pointed out that measurement of CA125 in the blood is the test currently used to monitor ovarian cancer treatment, follow patients for recurrence, and in some cases screen high-risk individuals to detect early-stage disease. In her conference talk, Christine Coticchia, Ph.D., Children's Hospital Boston and Harvard Medical School, emphasized that CA125 is relatively nonspecific for ovarian cancer and uninformative in a substantial percentage of patients. Dr. Coticchia and colleagues are studying a combination of two matrix metalloproteases, MMP-2 and MMP-9, in urine for their utility as biomarkers to predict the presence of ovarian cancer in women with normal CA125 levels.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. JAMA study reports on fatty liver disease in children and teens
2. Making temporary changes to brain could speed up learning, study reports
3. U.S. Reports Drop in AIDS-Related Cancers
4. U.S. Reports Continuing Drop in Birth Rate
5. Case study reports singing lowers patients blood pressure prior to surgery
6. Study finds reports of domestic violence rise 10 percent after NFL upsets
7. U.S. Flu Season Picking Up, CDC Reports
8. Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS
9. Burden of HIV Highest for Blacks, CDC Reports
10. International research team reports major findings in prevention and treatment of blood clots
11. New study reports effects of endurance running
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GEN reports on novel noninvasive tests for early cancer detection
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology: